Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP520731.RABOH0ZhnBrV8oo_uvaRAO06wC0IWzGk2rUnKtRlWBa_Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP520731.RABOH0ZhnBrV8oo_uvaRAO06wC0IWzGk2rUnKtRlWBa_Q130_assertion type Assertion NP520731.RABOH0ZhnBrV8oo_uvaRAO06wC0IWzGk2rUnKtRlWBa_Q130_head.
- NP520731.RABOH0ZhnBrV8oo_uvaRAO06wC0IWzGk2rUnKtRlWBa_Q130_assertion description "[Taken together, these data indicated that silibinin inhibits LoVo cell invasion with the reduction of MMP-2 presentation by attenuating AP-1 binding activity, suggesting a novel antimetastatic application for silibinin in colon cancer chemoprevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP520731.RABOH0ZhnBrV8oo_uvaRAO06wC0IWzGk2rUnKtRlWBa_Q130_provenance.
- NP520731.RABOH0ZhnBrV8oo_uvaRAO06wC0IWzGk2rUnKtRlWBa_Q130_assertion evidence source_evidence_literature NP520731.RABOH0ZhnBrV8oo_uvaRAO06wC0IWzGk2rUnKtRlWBa_Q130_provenance.
- NP520731.RABOH0ZhnBrV8oo_uvaRAO06wC0IWzGk2rUnKtRlWBa_Q130_assertion SIO_000772 23210512 NP520731.RABOH0ZhnBrV8oo_uvaRAO06wC0IWzGk2rUnKtRlWBa_Q130_provenance.
- NP520731.RABOH0ZhnBrV8oo_uvaRAO06wC0IWzGk2rUnKtRlWBa_Q130_assertion wasDerivedFrom befree-20150227 NP520731.RABOH0ZhnBrV8oo_uvaRAO06wC0IWzGk2rUnKtRlWBa_Q130_provenance.
- NP520731.RABOH0ZhnBrV8oo_uvaRAO06wC0IWzGk2rUnKtRlWBa_Q130_assertion wasGeneratedBy ECO_0000203 NP520731.RABOH0ZhnBrV8oo_uvaRAO06wC0IWzGk2rUnKtRlWBa_Q130_provenance.